Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 446

1.

Experimental Spinal Cord Injury Causes Left-Ventricular Atrophy and Is Associated with an Upregulation of Proteolytic Pathways.

Poormasjedi-Meibod MS, Mansouri M, Fossey M, Squair JW, Liu J, McNeill JH, West CR.

J Neurotrauma. 2019 Mar 19;36(6):950-961. doi: 10.1089/neu.2017.5624. Epub 2018 Aug 13.

PMID:
29877162
2.

Cardiac Consequences of Autonomic Dysreflexia in Spinal Cord Injury.

West CR, Squair JW, McCracken L, Currie KD, Somvanshi R, Yuen V, Phillips AA, Kumar U, McNeill JH, Krassioukov AV.

Hypertension. 2016 Nov;68(5):1281-1289. Epub 2016 Oct 3.

PMID:
27698067
3.

Glucose lowering effect of montbretin A in Zucker Diabetic Fatty rats.

Yuen VG, Coleman J, Withers SG, Andersen RJ, Brayer GD, Mustafa S, McNeill JH.

Mol Cell Biochem. 2016 Jan;411(1-2):373-81. doi: 10.1007/s11010-015-2599-4. Epub 2015 Nov 7.

PMID:
26547551
4.

Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome.

Gershkovich P, Wasan KM, Ribeyre C, Ibrahim F, McNeill JH.

Drugs Context. 2015 Aug 7;4:212287. doi: 10.7573/dic.212287. eCollection 2015.

5.

The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif.

Williams LK, Zhang X, Caner S, Tysoe C, Nguyen NT, Wicki J, Williams DE, Coleman J, McNeill JH, Yuen V, Andersen RJ, Withers SG, Brayer GD.

Nat Chem Biol. 2015 Sep;11(9):691-6. doi: 10.1038/nchembio.1865. Epub 2015 Jul 27.

PMID:
26214255
6.

Combined metoprolol and ascorbic acid treatment prevents intrinsic damage to the heart during diabetic cardiomyopathy.

Saran V, Sharma V, Wambolt R, Yuen VG, Allard M, McNeill JH.

Can J Physiol Pharmacol. 2014 Oct;92(10):827-37. doi: 10.1139/cjpp-2014-0078. Epub 2014 Aug 14.

PMID:
25229873
7.

Selective alpha(1)-adrenoceptor blockade prevents fructose-induced hypertension.

Tran LT, MacLeod KM, McNeill JH.

Mol Cell Biochem. 2014 Jul;392(1-2):205-11. doi: 10.1007/s11010-014-2031-5. Epub 2014 Mar 29.

PMID:
24682694
8.

Passive hind-limb cycling improves cardiac function and reduces cardiovascular disease risk in experimental spinal cord injury.

West CR, Crawford MA, Poormasjedi-Meibod MS, Currie KD, Fallavollita A, Yuen V, McNeill JH, Krassioukov AV.

J Physiol. 2014 Apr 15;592(8):1771-83. doi: 10.1113/jphysiol.2013.268367. Epub 2014 Feb 17.

9.

The effects of phentolamine on fructose-fed rats.

Zhou K, Kumar U, Yuen VG, McNeill JH.

Can J Physiol Pharmacol. 2012 Aug;90(8):1075-85. doi: 10.1139/y2012-063. Epub 2012 Jul 11.

PMID:
22783820
10.
11.

Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats.

Vasudevan H, Yuen VG, McNeill JH.

Mol Cell Biochem. 2012 Jan;359(1-2):409-18. doi: 10.1007/s11010-011-1035-7. Epub 2011 Sep 6.

PMID:
21894443
12.

Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.

Nagareddy PR, Rajput PS, Vasudevan H, McClure B, Kumar U, Macleod KM, McNeill JH.

Br J Pharmacol. 2012 Feb;165(3):705-15. doi: 10.1111/j.1476-5381.2011.01583.x.

13.

β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.

Sharma V, Sharma A, Saran V, Bernatchez PN, Allard MF, McNeill JH.

Eur J Pharmacol. 2011 Apr 25;657(1-3):117-25. doi: 10.1016/j.ejphar.2011.01.044. Epub 2011 Feb 4.

PMID:
21296063
14.

GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.

Nagareddy PR, MacLeod KM, McNeill JH.

Cardiovasc Res. 2010 Jul 1;87(1):177-86. doi: 10.1093/cvr/cvq030. Epub 2010 Jan 28.

PMID:
20110336
15.

Effects of insulin resistance and testosterone on the participation of cyclooxygenase isoforms in vascular reactivity.

Vasudevan H, Lau S, Jiang J, McNeill JH.

J Exp Pharmacol. 2010 Dec 1;2:169-79. doi: 10.2147/JEP.S14989. eCollection 2010.

16.

Functional effects of protein kinases and peroxynitrite on cardiac carnitine palmitoyltransferase-1 in isolated mitochondria.

Sharma V, Abraham T, So A, Allard MF, McNeill JH.

Mol Cell Biochem. 2010 Apr;337(1-2):223-37. doi: 10.1007/s11010-009-0303-2. Epub 2009 Oct 28.

PMID:
19862603
17.

Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats.

Tsai GY, Cui JZ, Syed H, Xia Z, Ozerdem U, McNeill JH, Matsubara JA.

Clin Exp Ophthalmol. 2009 Mar;37(2):223-31. doi: 10.1111/j.1442-9071.2009.02000.x. Epub 2009 Feb 3.

18.

Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?

Mustafa S, Sharma V, McNeill JH.

Exp Clin Cardiol. 2009 Summer;14(2):e41-50.

19.

Renal expression of arachidonic acid metabolizing enzymes and RhoA/Rho kinases in fructose insulin resistant hypertensive rats.

Mustafa S, Vasudevan H, Yuen VG, McNeill JH.

Mol Cell Biochem. 2010 Jan;333(1-2):203-9. doi: 10.1007/s11010-009-0220-4. Epub 2009 Jul 25.

PMID:
19633817
20.

Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.

Nagareddy PR, Soliman H, Lin G, Rajput PS, Kumar U, McNeill JH, MacLeod KM.

Diabetes. 2009 Oct;58(10):2355-64. doi: 10.2337/db09-0432. Epub 2009 Jul 8.

21.

Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis.

Nagareddy PR, Chow FL, Hao L, Wang X, Nishimura T, MacLeod KM, McNeill JH, Fernandez-Patron C.

Cardiovasc Res. 2009 Dec 1;84(3):368-77. doi: 10.1093/cvr/cvp230. Epub 2009 Jul 3.

PMID:
19578070
22.

Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism.

Sharma V, Mustafa S, Patel N, Wambolt R, Allard MF, McNeill JH.

Eur J Pharmacol. 2009 Sep 1;617(1-3):113-7. doi: 10.1016/j.ejphar.2009.06.037. Epub 2009 Jun 30.

PMID:
19573526
23.

The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Tran LT, Yuen VG, McNeill JH.

Mol Cell Biochem. 2009 Dec;332(1-2):145-59. doi: 10.1007/s11010-009-0184-4. Epub 2009 Jun 18. Review.

PMID:
19536638
24.

To scale or not to scale: the principles of dose extrapolation.

Sharma V, McNeill JH.

Br J Pharmacol. 2009 Jul;157(6):907-21. doi: 10.1111/j.1476-5381.2009.00267.x. Epub 2009 Jun 5. Review.

25.

Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats.

Tran LT, MacLeod KM, McNeill JH.

Mol Cell Biochem. 2009 Oct;330(1-2):219-28. doi: 10.1007/s11010-009-0136-z. Epub 2009 May 7.

PMID:
19440659
26.

Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.

Nagareddy PR, McNeill JH, MacLeod KM.

Eur J Pharmacol. 2009 Jun 2;611(1-3):53-9. doi: 10.1016/j.ejphar.2009.03.061. Epub 2009 Apr 1.

PMID:
19344709
27.

Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.

Sharma V, Dhillon P, Parsons H, Allard MF, McNeill JH.

Eur J Pharmacol. 2009 Apr 1;607(1-3):156-66. doi: 10.1016/j.ejphar.2009.02.016. Epub 2009 Feb 20.

PMID:
19233164
28.

Vanadium treatment of type 2 diabetes: a view to the future.

Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C.

J Inorg Biochem. 2009 Apr;103(4):554-8. doi: 10.1016/j.jinorgbio.2008.12.003. Epub 2008 Dec 24. Review.

PMID:
19162329
29.

Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.

Tran LT, MacLeod KM, McNeill JH.

Mol Cell Biochem. 2009 May;325(1-2):89-97. doi: 10.1007/s11010-008-0023-z. Epub 2009 Jan 13.

PMID:
19139972
30.

Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3.

Sharma V, Parsons H, Allard MF, McNeill JH.

Eur J Pharmacol. 2008 Oct 24;595(1-3):44-51. doi: 10.1016/j.ejphar.2008.07.042. Epub 2008 Jul 30.

PMID:
18703049
31.

Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.

Soliman H, Craig GP, Nagareddy P, Yuen VG, Lin G, Kumar U, McNeill JH, Macleod KM.

Cardiovasc Res. 2008 Jul 15;79(2):322-30. doi: 10.1093/cvr/cvn095. Epub 2008 Apr 14.

PMID:
18411229
32.

One and two dimensional pulsed electron paramagnetic resonance studies of in vivo vanadyl coordination in rat kidney.

Dikanov SA, Liboiron BD, Thompson KH, Vera E, Yuen VG, McNeill JH, Orvig C.

Bioinorg Chem Appl. 2003:69-83. doi: 10.1155/S1565363303000062.

33.

Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.

Sharma V, Dhillon P, Wambolt R, Parsons H, Brownsey R, Allard MF, McNeill JH.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1609-20. doi: 10.1152/ajpheart.00949.2007. Epub 2008 Jan 18.

34.

Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats.

Guo Z, Xia Z, Yuen VG, McNeill JH.

Metabolism. 2007 Oct;56(10):1363-71.

PMID:
17884446
35.

Endothelin-1 blockade prevents COX2 induction and TXA2 production in the fructose hypertensive rat.

Jiang J, Tran L, Vasudevan H, Xia Z, Yuen VG, McNeill JH.

Can J Physiol Pharmacol. 2007 Mar-Apr;85(3-4):422-9.

PMID:
17612651
36.

Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats.

Lin G, Craig GP, Zhang L, Yuen VG, Allard M, McNeill JH, MacLeod KM.

Cardiovasc Res. 2007 Jul 1;75(1):51-8. Epub 2007 Mar 14.

PMID:
17428455
37.

N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats.

Xia Z, Kuo KH, Nagareddy PR, Wang F, Guo Z, Guo T, Jiang J, McNeill JH.

Cardiovasc Res. 2007 Mar 1;73(4):770-82. Epub 2006 Nov 30.

PMID:
17250813
38.

Chronic estrogen treatment reduces vaso-constrictor responses in insulin resistant rats.

Song D, Yuen VG, Yao L, McNeill JH.

Can J Physiol Pharmacol. 2006 Nov;84(11):1139-43.

PMID:
17218978
39.

Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine.

Guo Z, Xia Z, Jiang J, McNeill JH.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1728-36. Epub 2006 Nov 22.

40.

Effects of endothelin receptor blockade on hypervasoreactivity in streptozotocin-diabetic rats: vessel-specific involvement of thromboxane A2.

Arikawa E, Cheung C, Sekirov I, Battell ML, Yuen VG, McNeill JH.

Can J Physiol Pharmacol. 2006 Aug-Sep;84(8-9):823-33.

PMID:
17111027
42.
43.

The etiology of hypertension in the metabolic syndrome part two: the gene-environment interaction.

Sharma V, McNeill JH.

Curr Vasc Pharmacol. 2006 Oct;4(4):305-20. Review.

PMID:
17073700
44.
45.

N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression.

Xia Z, Liu M, Wu Y, Sharma V, Luo T, Ouyang J, McNeill JH.

Eur J Pharmacol. 2006 Nov 21;550(1-3):134-42. Epub 2006 Sep 7.

PMID:
17026986
46.

Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats.

Xia Z, Guo Z, Nagareddy PR, Yuen V, Yeung E, McNeill JH.

Eur J Pharmacol. 2006 Aug 21;544(1-3):118-25. Epub 2006 Jun 23.

PMID:
16859669
47.

Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertension.

Vasudevan H, Nagareddy PR, McNeill JH.

Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H3058-64. Epub 2006 Jun 30.

48.

Chronic cobalt treatment decreases hyperglycemia in streptozotocin-diabetic rats.

Vasudevan H, McNeill JH.

Biometals. 2007 Apr;20(2):129-34. Epub 2006 Jun 27.

PMID:
16802070
49.

N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.

Nagareddy PR, Xia Z, MacLeod KM, McNeill JH.

J Cardiovasc Pharmacol. 2006 Apr;47(4):513-20.

PMID:
16680064
50.

Diabetic cardiomyopathy: where are we 40 years later?

Sharma V, McNeill JH.

Can J Cardiol. 2006 Mar 15;22(4):305-8. Review.

Supplemental Content

Loading ...
Support Center